|
|
Other links at Articles > Pediatrics |
| 4. |
Dexrazoxane Not Linked With Secondary Cancers in Children With ALL
|
|
|
Dexrazoxane, which is used to prevent anthracycline-induced myocardial toxicity, does not appear to increase the risk of secondary malignant neoplasms in children with high-risk acute lymphoblastic leukemia (ALL), according to a paper in the March 1 issue of the Journal of Clinical Oncology. Reuters Health Information
|
|
|